Ziegler Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-21,490
| Closed | -$779K | – | 425 |
|
|
2023
Q1 | $779K | Buy |
21,490
+210
| +1% | +$7.61K | 0.03% | 318 |
|
|
2022
Q4 | $759K | Sell |
21,280
-4,962
| -19% | -$177K | 0.03% | 317 |
|
|
2022
Q3 | $888K | Sell |
26,242
-154
| -0.6% | -$5.21K | 0.04% | 311 |
|
|
2022
Q2 | $763K | Buy |
26,396
+719
| +3% | +$20.8K | 0.03% | 331 |
|
|
2022
Q1 | $830K | Sell |
25,677
-2,100
| -8% | -$67.9K | 0.04% | 318 |
|
|
2021
Q4 | $810K | Sell |
27,777
-9,060
| -25% | -$264K | 0.03% | 341 |
|
|
2021
Q3 | $982K | Buy |
36,837
+9,362
| +34% | +$250K | 0.04% | 332 |
|
|
2021
Q2 | $846K | Sell |
27,475
-881
| -3% | -$27.1K | 0.03% | 350 |
|
|
2021
Q1 | $742K | Sell |
28,356
-759
| -3% | -$19.9K | 0.02% | 360 |
|
|
2020
Q4 | $733K | Buy |
29,115
+5,857
| +25% | +$147K | 0.02% | 358 |
|
|
2020
Q3 | $485K | Buy |
+23,258
| New | +$485K | 0.02% | 376 |
|